A double-blind evaluation of diazepam and amylobarbitone in acute myocardial infarction.
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000654:Amobarbital / Q000009:adverse effects / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000150:complications; D001519:Behavior / Q000187:drug effects; D002986:Clinical Trials as Topic; D003975:Diazepam / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000150:complications; D006801:Humans; D007022:Hypotension / Q000150:complications; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D011569:Psychiatric Status Rating Scales; D012770:Shock, Cardiogenic / Q000150:complications
D000654:Amobarbital; D003975:Diazepam